Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 14, 2015; 21(2): 675-687
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.675
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.675
Table 3 Classification of sclerosing encapsulating peritonitis according to underlying cause
Primary (idiopathic) sclerosing encapsulating peritonitis |
I Adolescent form |
II Adult form |
Secondary sclerosing encapsulating peritonitis |
I Systemically induced by |
Beta adrenergic blocking agents |
Practolol |
Timolol |
Propanolol |
Other drugs |
Methotrexate |
Protein S deficiency |
Exposure to asbestosis |
II Induced by possible local and/or systemic irritants |
Peritoneal dialysis |
Abdominal trauma |
Abdominal surgery |
Liver transplantation |
Peritoneovenous shunt |
Ventriculoperitoneal shunt |
Peritoneal sarcoidosis |
Liver cirrhosis |
Peritoneal tuberculosis |
Sarcoidosis |
Familial mediterranean fever |
Systemic lupus erythematosus |
Gastrointestinal malignancy |
Intraperitoneal chemotherapy |
Fibrogenic foreign body |
Endometriosis |
Dermoid cyst rupture |
Luteinized ovarian thecomas |
Cytomegalovirus peritonitis |
Recurrent peritonitis |
Granulomatous peritonitis related with parasitic infestation |
- Citation: Akbulut S. Accurate definition and management of idiopathic sclerosing encapsulating peritonitis. World J Gastroenterol 2015; 21(2): 675-687
- URL: https://www.wjgnet.com/1007-9327/full/v21/i2/675.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i2.675